Benefits of an insulin dosage calculation device for adolescents with type 1 diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 17, Issue 12, 2004, Pages 1641-1651

  Glaser, Nicole S ^a   Iden, Sultanna B ^a   Green Burgeson, Dayna ^a   Bennett, Claire ^a   Hood Johnson, Karen ^a   Styne, Dennis M ^a   Goodlin Jones, Beth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adherence; Adolescents; Diabetes mellitus; HbA1c treatment satisfaction

Indexed keywords

CARBOHYDRATE; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ANALYTICAL ERROR; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DISEASE CONTROL; DOSE CALCULATION; FEEDING BEHAVIOR; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 11044225120     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2004.17.12.1641     Document Type: Article

References (27)

1. The Diabetes Control and Complications Trial Research Group. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 2001; 139: 804-812.
2. The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994; 125: 177-188.
3. Tamborlane W, Ahern J. Implications and results of the Diabetes Control and Complications Trial. Pediatr Clin North Am 1997; 44: 285-300.
4. American Diabetes Association. Implications of the Diabetes Control and Complications Trial. Diabetes Care 2002; 25: S25-27.
5. Amiel S, Sherwin R, Simonson D, Lauritano A, Tamborlane W. Impaired insulin action in puberty; a contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1986; 315: 215-219.
6. 1c over 10+ years: good metabolic control in prepuberty predicts better control in adult type 1 diabetes. Diabetes 2002; 51: A4.
7. Grey M, Insabella G, Knafl G. Intensive therapy in adolescence and quality of life in young adulthood. Diabetes 2002; 51: A17.
8. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
9. Wysocki T, Taylor A, Hough B, Linscheid T, Yeates K, Naglieri J. Deviation from developmentally appropriate self-care autonomy; association with diabetes outcomes. Diabetes Care 1996; 19: 119-125.
10. Weissberg-Benchell J, Glasgow A, Tynan W, Wirtz P, Turek J, Ward J. Adolescent diabetes management and mismanagement. Diabetes Care 1995; 18: 77-82.
11. Kovacs M, Goldston D, Obrosky S, Iyengar S. Prevalence and predictors of pervasive noncompliance with medical treatment among youths with insulin-dependent diabetes mellitus. J Am Acad Child Adolesc Psychiatry 1992; 31: 1112-1119.
12. Wysocki T. Associations among teen-parent relationships, metabolic control, and adjustment to diabetes in adolescents. J Pediatr Psychol 1993; 18: 441-452.
13. Anderson B, Ho J, Brackett J, Finkelstein D, Laffel L. Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. J Pediatr 1997; 130: 257-265.
14. Kraus B. Calories and Carbohydrates. New York: Penguin Putnam Books, 1997.
15. Brownlee-Duffeck M, Peterson L, Simonds J, Goldstein D, Kilo C, Hoette S. The role of health beliefs in the regimen adherence and metabolic control of adolescents and adults with diabetes mellitus. J Consult Clin Psychol 1987; 55: 139-144.
16. Lewis K, Bradley C, Knight G, Boulton A, Ward J. A measure of treatment satisfaction designed specifically for people with insulin-dependent diabetes. Diabet Med 1988; 5: 235-242.
17. The Diabetes Control and Complications Trial Research Group. Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). Diabetes Care 1988; 11: 725-732.
18. Jacobson A, Samson J, DeGroot M. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 1994; 17: 267-274.
19. The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on quality of life outcomes in the Diabetes Control and Complications Trial. Diabetes Care 1996; 19: 195-203.
20. StataCorp. Stata Statistical Software: Release 6.0. College Station, TX: Stata Corporation, 1999.
21. Weissberg-Benchell J, Goodman S, Antisdel J. CSII decision making by pediatric diabetes clinicians. Diabetes 2002; 51: A17.
22. Wysocki T, Meinhold P, Abrams K, Barnard M, Clarke W, Bellando B, Bourgeois M. Parental and professional estimates of self-care independence of children and adolescents with IDDM. Diabetes Care 1992; 15: 43-52.
23. Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet 1997; 350: 1505-1510.
24. Altobelli E, Valenti M, Verrotti A, Masedu F, Tiberti S, Chiarelli F, DiOrio F. Family and disease management in young type 1 diabetic patients. Acta Diabetol 2000; 37: 173-178.
25. Auslander W, Jung K, Miller P, Santiago J. Assessing family sharing of diabetes responsibilities. J Pediatr Psychol 1990; 15: 477-492.
26. Wilson D, Endres R. Compliance with blood glucose monitoring in children with type 1 diabetes mellitus. J Pediatr 1986; 108: 1022-1024.
27. Boland E, Grey M, Oesterle A, Fredrickson L, Tamborlane W. Continuous subcutaneous insulin infusion; a new way to lower risk of severe hypoglycemia, improve metabolic control and enhance coping in adolescents. Diabetes Care 1999; 22: 1779-1784.